Oxford Global are pleased to announce the return of the Pharma R&D Europe Series, the leading pharmaceutical discussion forum in Europe.

The series is made up of the following events:

• 15th Annual Drug Discovery Summit 
• 6th Annual Drug Development Congress 
• 2nd Annual Discovery Chemistry & Drug Design Congress

The first round of topics have now been confirmed for the 15th Annual Drug Discovery Summit, taking place on the 2nd & 3rd June 2014 in Geneva, Switzerland.

?Co-located with our 2nd Annual Discovery Chemistry congress, the 15th Annual Drug Discovery Summit topics include: 

Diversity Screening at AstraZeneca: Lead Generation Through Internal Delivery and External Collaboration

   Development of the diversity screening strategy for 2014-2017 

   Enabling a capability for phenotypic discovery 

   Leveraging capability for Open Innovation

?CONFIRMED SPEAKER: ?Steve Rees, Vice President, Screening Sciences and Sample Management, AstraZeneca 

Disease Modeling And Phenotypic Drug Screening For Diabetic Cardiomyopathy Using Human Induced Pluripotent Stem Cells

   Diabetic cardiomyopathy can be induced in vitro by environmental or genetic means 

   The extent of patient-specific cardiomyopathy is clinically correlated 

   Phenotypic screening identifies drugs that rescue the disease phenotype

Roberto Iacone, Group Head, Roche-Basel 

3D and Phenotypic Screening: Where Do We Go In The Third Dimension?

   Relevance of cellular models for drug discovery 

   Infrastructure for 3D and Phenotypic screening 

   Outcome comparison for 2D and 3D screening

?Adam Hill, Director, Head of Screening, Novartis 

Our speaker programmes have been carefully researched, ensuring delegates are exposed to the highest level of expertise. Confirmed speakers so far include:

   Steve Rees, Vice President, Screening Sciences and Sample Management, AstraZeneca 

   Robert Hayes, Vice President and Venture Leader, Centyrex Venture, Janssen 

   Richard Sedrani, Executive Director, CPC / Expertise Platform Proteases / Medicinal Chemistry ?Unit, Novartis 

   Ashwani Bahl, Senior Director Global External Research & Development, Eli Lilly 

   Eckhard Ottow, Head Global External Innovation & Alliances Global Drug Discovery, Bayer ?HealthCare Pharmaceuticals 

   Charlotte Deane, Director of the Systems Approaches to Biomedical Sciences Industrial DTC, ?Oxford University

Register your interest today to hear over 55 outstanding case studies and presentations, across 6 interactive streams:

  R&D Models For The Future 

   Screening & Assays: Enabling Technologies 

   Target Based Discovery 

   Supporting Innovation: Data & Information Management 

   Discovery Chemistry: Latest Case Studies 

   Drug Design: Novel Approaches

?Your booking will give you free access to the 6th Annual Drug Development Congress and the 2nd Annual Discovery Chemistry & Drug Design Congress

?The Discovery Chemistry & Drug Design Congress proved a popular addition to the summit last year. This year the congress will include key case studies in chemical genetics, computational chemistry and flow chemistry. Presentations will also focus on early de-risking through drug design, focusing on the areas such as solubility, potency and selectivity. 

list of speakers 

?download the conference programme 

more about oxford global